This is in addition to checking for the disease in patients with diabetes, hypertension and cardiovascular disease (CVD).
But the guidelines do not endorse whole-population screening for CKD, as proposed by prime minister Gordon Brown earlier this year.
The draft guidance states that in the absence of risk factors 'age, gender, ethnicity or BMI should not be used as risk markers to test for CKD'.
DoH renal czar Dr Donal O'Donogue said that there was not yet enough evidence to support widespread population screening for CKD.
'In due course, if there is a value in screening then we will move in that direction,' he said. 'But we don't yet have the evidence to show that it is worthwhile.'
Draft NICE guidelines recommend CKD testing in patients with:
- Diabetes (type-1 and -2).
- On potentially nephrotoxic drugs.
- Structural renal tract disease, renal calculi or prostatic hypertrophy.
- Family history of stage 5 CKD or hereditary kidney disease.
- Incidental haematuria or proteinuria.